And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal
Revvity, Inc. (NYSE: RVTY) today announced the launch of the Auto-Pure 2400 liquid handler from Allsheng for use with the T-SPOT.TB test. The Auto-Pure 2400 platform is
You’re reading this week’s edition of the New Cannabis Ventures weekly newsletter, which we have been publishing since October 2015. The newsletter includes unique insight
Global leaders highlight the need to defeat meningitis – a leading cause of disability – at a high-level meeting co-hosted by the World Health Organization
New evidence from the World Health Organization shows the extensive overuse of antibiotics during COVID-19 pandemic worldwide, which may have exacerbated “silent” spread of antimicrobial
With little pomp, California launched two apps at the start of the year offering free behavioral health services to youths to help them cope with
The real-world safety and efficacy of sacituzumab govitecan (SG) against metastatic triple-negative breast cancer.
Share this article Cerevance’s CVN424 is a non-dopamine G protein-coupled receptor 6 (GPR6) inhibitor. Image Credit: Pla2na / Shutterstrock. US-based Cerevance has secured $47m in
Share this article MSD expects sales for full-year 2024 to be in the range of $63.1bn to $64.3bn. Credit: Michael Vi via Shutterstock. Merck &
Share this article The automation of cell isolation is said to be a key step in improving the efficiency and scalability of cell therapies. Credit: